Overview
Chatonda Manda practices practicing medicine in Blantyre, Malawi.
Manda is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Primary Amebic Meningoencephalitis, Malaria, and Retinoblastoma.
They are actively involved in clinical research, co-authoring 10 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Chatonda S. Manda
Is Chatonda S. Manda a top-rated expert for Primary Amebic Meningoencephalitis?
MediFind is an objective health platform that identifies experts based on real-world data. Chatonda S. Manda is classified as an Advanced expert for Primary Amebic Meningoencephalitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Chatonda S. Manda participate in research or clinical trials?
Yes. Chatonda S. Manda has published 10 articles and abstracts on conditions like Primary Amebic Meningoencephalitis. You can view a list of Chatonda S. Manda's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Primary Amebic Meningoencephalitis
- Experienced
- MalariaManda isExperienced. Learn about Malaria.
- RetinoblastomaManda isExperienced. Learn about Retinoblastoma.